Riskpilot← Back to searchSign inGet full accessTETRAO UROGALLUS AS
ASActiveOrg 915847897Årneshaugen 33, 7190 BessakerVeterinary activities · NACE 7500Est. 20150 employees
Revenue 2025
NOK 0
EBITDA margin
—
-3% vs 2024
Equity ratio
99.9%
Financial strength
Net profit 2025
NOK 1,1M
+54% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -51K | -3% |
| Net profit | NOK 1,1M | +54% |
| Total assets | NOK 1,8M | -13% |
| Equity | NOK 1,8M | +49% |
| Employees | 0 | — |
Legal name
TETRAO UROGALLUS AS
Org number
915847897
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
31. august 2015
Share capital
NOK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investeringer av aksjer og verdipapirer, eller aktiviteter som er beslektet med dette.
Address
Årneshaugen 33, 7190 Bessaker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 322 | 344 | 185 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 211 | 294 | −46 | −49 | −51 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 211 | 294 | −46 | −49 | −51 |
| Net financials | 455 | −225 | 410 | 740 | 1 115 |
| Profit before tax | 667 | 69 | 364 | 690 | 1 064 |
| Tax | 46 | 65 | −0 | −0 | −0 |
| Net profit | 620 | 5 | 364 | 690 | 1 064 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 981 | 2 006 | 2 177 | 2 056 | 1 796 |
| Equity | 1 927 | 1 931 | 1 366 | 1 206 | 1 795 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 54 | 75 | 811 | 850 | 1 |
| Total debt | 54 | 75 | 811 | 850 | 1 |
EBITDA margin
-5094300.0%
This company
15.8%
Market median
-32242505% vs market
20212025
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
59.3%
This company
18.4%
Market median
+222% vs market
20212025
Net profit margin
106357100.0%
This company
8.1%
Market median
+1313050517% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AN Chief Executive Officer | Chief Executive Officer | 2015 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TETRAO UROGALLUS AS (this company)
FOSEN VETERINÆRSENTER ASBoard members of TETRAO UROGALLUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne-Johan Nikolaisen | Chief Executive Officer | 0 companies |